Showing results (1-10 of 9) with videos related to

Sort By:
Pageof 1
Advanced Drug Delivery Reviews|December 23, 2008
Pharmacogenomics and -genetics in colorectal cancerAlexandra Pohl, Georg Lurje, Philipp C Manegold, et al.
Blood|February 14, 2003
Platelet-endothelial interaction in tumor angiogenesis and microcirculationPhilipp C Manegold, Joerg Hutter, Sascha A Pahernik, et al.
Molecular Cancer Therapeutics|April 23, 2009
Thymidylate synthase gene variations: predictive and prognostic markersGeorg Lurje, Philipp C Manegold, Yan Ning, et al.
Oncology (Williston Park, N.Y.)|May 14, 2008
Targeting metastatic colorectal cancer in 2008: a long way from 5-FUAlexandra Pohl, Wu Zhang, Yan Ning, et al.
International Journal of Cancer|June 19, 2009
The dual EGFR/HER-2 tyrosine kinase inhibitor lapatinib sensitizes colon and gastric cancer cells to the irinotecan active metabolite SN-38Melissa J LaBonte, Philipp C Manegold, Peter M Wilson, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|February 5, 2008
Antiangiogenic therapy with mammalian target of rapamycin inhibitor RAD001 (Everolimus) increases radiosensitivity in solid cancerPhilipp C Manegold, Carmen Paringer, Ulrike Kulka, et al.
Pharmacogenetics and Genomics|November 7, 2008
Polymorphisms in interleukin 1 beta and interleukin 1 receptor antagonist associated with tumor recurrence in stage II colon cancerGeorg Lurje, Andrew E Hendifar, Anne M Schultheis, et al.
International Journal of Cancer|July 22, 2010
Interleukin-8 is associated with proliferation, migration, angiogenesis and chemosensitivity in vitro and in vivo in colon cancer cell line modelsYan Ning, Philipp C Manegold, Young Kwon Hong, et al.
Molecular Cancer Research : MCR|April 12, 2011
A coactivator role of CARM1 in the dysregulation of β-catenin activity in colorectal cancer cell growth and gene expressionChen-Yin Ou, Melissa J LaBonte, Philipp C Manegold, et al.
Pageof 1